Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1179 |  KOD Kodiak Sciences Inc - Common Stock | 94.26 USD | +3.49% | -3.96% | +183.15% | +603.43% | 5.92 B USD | ||
| 1182 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 295.00 USD | +0.59% | -4.08% | +2.42% | +57.65% | 5.88 B USD | ||
| 1248 |  ERAS Erasca, Inc. - Common Stock | 15.46 USD | +9.49% | +4.39% | +0.59% | +538.84% | 5.41 B USD | ||
| 1266 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 81.35 USD | +0.88% | -3.93% | -17.01% | +16.00% | 5.28 B USD | ||
| 1272 |  PTCT PTC Therapeutics, Inc. - Common Stock | 62.56 USD | -1.06% | -3.47% | -6.40% | -5.17% | 5.22 B USD | ||
| 1273 |  COGT Cogent Biosciences, Inc. - Common Stock | 30.08 USD | -0.20% | -6.35% | -14.28% | +91.96% | 5.22 B USD | ||
| 1284 |  SRRK Scholar Rock Holding Corporation - Common Stock | 42.20 USD | 0.00% | -9.71% | -26.38% | +40.57% | 5.14 B USD | ||
| 1317 |  TVTX Travere Therapeutics, Inc. - Common Stock | 52.04 USD | -2.62% | -9.04% | -20.91% | +80.88% | 4.91 B USD | ||
| 1318 |  CRSP CRISPR Therapeutics AG - Common Shares | 50.44 USD | -3.65% | -10.65% | -3.92% | -34.77% | 4.88 B USD | ||
| 1360 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.43 USD | -2.89% | -7.43% | -22.15% | +136.66% | 4.61 B USD | ||
| 1364 |  DFTX Definium Therapeutics, Inc. - Common Shares | 34.18 USD | -2.59% | -9.34% | -9.62% | +126.21% | 4.59 B USD | ||
| 1417 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.23 USD | -0.86% | -4.34% | -8.83% | +157.58% | 4.26 B USD | ||
| 1436 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 26.09 USD | -0.72% | -5.44% | +8.48% | +51.16% | 4.16 B USD | ||
| 1498 |  RLAY Relay Therapeutics, Inc. - Common Stock | 17.41 USD | -3.01% | -6.95% | -4.86% | +152.32% | 3.82 B USD | ||
| 1500 |  TNGX Tango Therapeutics, Inc. - Common Stock | 22.57 USD | +3.39% | -10.04% | -2.55% | +204.59% | 3.81 B USD | ||
| 1510 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.01 USD | -0.99% | +3.48% | -8.93% | +74.48% | 3.73 B USD | ||
| 1517 |  ABCL AbCellera Biologics Inc. - Common Shares | 12.02 USD | -6.31% | -14.75% | +11.40% | +103.38% | 3.69 B USD | ||
| 1549 |  VCYT Veracyte, Inc. - Common Stock | 43.60 USD | +1.02% | -2.98% | +1.89% | +18.16% | 3.51 B USD | ||
| 1550 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 36.16 USD | -0.69% | -7.52% | -38.75% | -11.35% | 3.50 B USD | ||
| 1553 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.06 USD | -0.55% | -6.39% | -7.16% | +10.68% | 3.48 B USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |